Amy E. McKee

CIK: 0001883764

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (87.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BCRX

BIOCRYST PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 31, 2026
Award(A)
Direct
644 shares at avg. $9.70$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 11, 2026
Award(A)
Direct
15.3K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
May 29, 2026
Award(A)
Direct
631 shares at avg. $8.91$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
May 18, 2026
Sale(S)
Direct
11.2K shares at avg. $8.97$100K
BCRX
BIOCRYST PHARMACEUTICALS INC
Feb 27, 2026
Award(A)
Direct
642 shares at avg. $8.75$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Nov 28, 2025
Award(A)
Direct
783 shares at avg. $7.18$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 29, 2025
Award(A)
Direct
676 shares at avg. $8.31$6K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 12, 2025
Award(A)
Direct
12.5K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	644	$9.70	$6,247	Direct
Jun 11, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	15,294	-	$0	Direct
May 29, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	631	$8.91	$5,622	Direct
May 18, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	11,180	$8.97	$100,285	Direct
Feb 27, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	642	$8.75	$5,618	Direct
Nov 28, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	783	$7.18	$5,622	Direct
Aug 29, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	676	$8.31	$5,618	Direct
Jun 12, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	12,500	-	-	Direct

1-8 of 8 transactions

About McKee Amy E

McKee Amy E (SEC CIK 0001883764) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX).

Signal8 holds 8 ownership filings by McKee Amy E, all Form 4s, filed between Jun 16, 2025 and Sep 2, 2026. Those filings report 8 transactions, from Jun 12, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McKee Amy E's filings is in DURHAM, NC.

Recent filings by McKee Amy E

Aug 31, 2026: Grant or award of BCRX shares (Form 4, code A).
Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
May 29, 2026: Grant or award of BCRX shares (Form 4, code A).
May 18, 2026: Open-market sale of BCRX shares (Form 4, code S).
Feb 27, 2026: Grant or award of BCRX shares (Form 4, code A).

Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)

Stonehouse Jon P, Director
Milne Jill C., Director
MILANO VINCENT, Director
Frank Steven, Director
Galson Steven K, Director
LEVIN ALAN G, Director

How to read Form 4 transaction codes